Subject
Immunology,Immunology and Allergy
Reference42 articles.
1. Efficacy and safety of CAR-T cell products axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel for the treatment of hematologic malignancies: a systematic review and meta-analysis;Meng;Front. Oncol.,2021
2. Toward better understanding and management of CAR-T cell-associated toxicity;Schmidts;Annu. Rev. Med.,2021
3. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells;Lee;Biol. Blood Marrow Transplant.,2019
4. Neurological updates: neurological complications of CAR-T therapy;Tallantyre;J. Neurol.,2021
5. Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy;Chou;Expet Opin. Biol. Ther.,2020